ASH Ashland Inc.
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.…
Industry Peers
Specialty ChemicalsKey Statistics
About Ashland (NYSE: ASH)
›
Ashland (NYSE: ASH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 2,800 employees.
The shares were at 74.12 USD on 19 November 2026, up 46.0% over 52 weeks. Its 52-week range is 48.00 USD to 79.50 USD: the price is 6.8% below the high and 54.4% above the low.
At a market capitalisation of 3.39B USD, it trades at 134.8 times trailing earnings and 15.1 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a premium of 297% for ASH. It pays a dividend yielding 2.20% (it pays out 107% of its earnings), against a median of 1.76% among the dividend payers in that peer group.
Ashland reports return on equity of 1.3%, an operating margin of 6.1% and revenue up 4.4% year over year.
Its debt exceeds its cash by 992.00M USD, a debt-to-equity ratio of 0.78. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 11 analysts cover the stock, with an average rating of Buy; their mean price target of 82.45 USD is 11.2% above the current price. The next earnings report is expected on 1 February 2027.